日本 2026年
The advancements in regenerative medicine, particularly since the Nobel Prize awarded to Professor Shinya Yamanaka in 2012, have significantly inspired growth and new entrants both in Japan and abroad. Despite this progress, Japan faces challenges, particularly in the commercialization of regenerative medical products compared to nations like the U.S., Europe, and South Korea. BioJapan serves not just as an exhibition for cutting-edge research and products but also as a platform for international seminars and commercial negotiations, further buttressing the practical application and industrialization of regenerative medicine. Additionally, the event emphasizes the merging of healthcare with digital technology, addressing the growing demand for contactless solutions in the wake of the pandemic. By showcasing innovative healthcare solutions combined with digital technologies, BioJapan aims to create new market opportunities and bolster business collaborations across the healthcare spectrum.